|
"chng wee joo"的相關文件
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立成功大學 |
2016-03 |
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
|
Kim, Seok Jin;Yoon, Dok Hyun;Jaccard, Arnaud;Chng, Wee Joo;Lim, Soon Thye;Hong, Huangming;Park, Yong;Chang, Kian Meng;Maeda, Yoshinobu;Ishida, Fumihiro;Shin, Dong-Yeop;Kim, Jin Seok;Jeong, Seong Hyun;Yang, Deok-Hwan;Jo, Jae-Cheol;Lee, Gyeong-Won;Choi, Chul Won;Lee, Won-Sik;Chen, Tsai-Yun;Kim, Kiyeun;Jung, Sin-Ho;Murayama, Tohru;Oki, Yasuhiro;Advani, Ranjana;d'Amore, Francesco;Schmitz, Norbert;Suh, Cheolwon;Suzuki, Ritsuro;Kwong, Yok Lam;Lin, Tong-Yu;Kim, Won Seog |
| 國立臺灣大學 |
2015 |
Primary Cutaneous NK/T-cell Lymphoma, Nasal Type and CD56-positive Peripheral T-cell Lymphoma A Cellular Lineage and Clinicopathologic Study of 60 Patients From Asia
|
Takata, Katsuyoshi; Hong, Min-eui; Sitthinamsuwan, Panitta; Loong, Florence; Tan, Soo-Yong; Liau, Jau-Yu; Hsieh, Pin-Pen; Ng, Siok-Bian; Yang, Sheau-Fang; Pongpruttipan, Tawatchai; Sukpanichnant, Sanya; Kwong, Yok-Lam; Ko, Young Hyeh; Cho, Yung-Tsu; Chng, Wee Joo; Matsushita, Takashi; Yoshino, Tadashi; Chuang, Shih-Sung; 廖肇裕 |
| 國立臺灣大學 |
2015 |
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose
|
Venkatakrishnan, Karthik; Kim, Tae Min; Lin, Chia-Chi; Thye, Lim Soon; Chng, Wee Joo; Ma, Brigette; Chen, Ming Huang; Zhou, Xiaofei; Liu, Hua; Kelly, Virginia; Kim, Won Seog; 林家齊 |
| 國立臺灣大學 |
2012 |
Clinical Profile of Multiple Myeloma in Asia - an Asian Myeloma Network (AMN) Study
|
Lee, Jae Hoon; Kim, Kihyun; Kim, Jin Seok; Min, Chang Ki; Yoon, Sung-Soo; Shimizu, Kazuyuki; Chou, Takaaki; Kosugi, Hiroshi; Suzuki, Kenshi; Hata, Hiroyuki; Chen, Wenming; Hou, Jian; Lu, Jin; Huang, Shang-Yi; Chng, Wee-Joo; Tan, Daryl; Teoh, Gerrard; Chim, James Chor Sang; Siritanaratkul, Noppadol; Nawarawong, Weerasak; Durie, Brian G. M.; 黃聖懿 |
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
|
